| Iluminação e arquitetura NS Vianna, JCS Gonçalves | 201 | 2001 |
| The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo … K Reich, M Gooderham, L Green, A Bewley, Z Zhang, I Khanskaya, ... Journal of the european academy of dermatology and venereology 31 (3), 507-517, 2017 | 194 | 2017 |
| Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for≥ 156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2) J Crowley, D Thaçi, P Joly, K Peris, KA Papp, J Goncalves, RM Day, ... Journal of the american academy of dermatology 77 (2), 310-317. e1, 2017 | 186 | 2017 |
| Arquitetura sustentável: uma integração entre ambiente, projeto e tecnologia em experiências de pesquisa, prática e ensino JCS Gonçalves, DHS Duarte Ambiente construído 6 (4), 51-81, 2006 | 177 | 2006 |
| Cannabis and its secondary metabolites: their use as therapeutic drugs, toxicological aspects, and analytical determination J Gonçalves, T Rosado, S Soares, AY Simão, D Caramelo, Â Luís, ... Medicines 6 (1), 31, 2019 | 170 | 2019 |
| Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: results of 2 phase III randomized, controlled trials (ESTEEM 1 … P Rich, M Gooderham, H Bachelez, J Goncalves, RM Day, R Chen, ... Journal of the American Academy of Dermatology 74 (1), 134-142, 2016 | 163 | 2016 |
| The environmental performance of tall buildings JCS Gonçalves, ÉM Umakoshi Routledge, 2010 | 131 | 2010 |
| Edifício ambiental JCS Gonçalves, K Bode Oficina de textos, 2015 | 93 | 2015 |
| Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and … R Bissonnette, DM Pariser, NR Wasel, J Goncalves, RM Day, R Chen, ... Journal of the American Academy of Dermatology 75 (1), 99-105, 2016 | 88 | 2016 |
| Mitochondrial DNA deletions are associated with non-B DNA conformations J Damas, J Carneiro, J Goncalves, JB Stewart, DC Samuels, A Amorim, ... Nucleic acids research 40 (16), 7606-7621, 2012 | 79 | 2012 |
| Florestais JLM Gonçalves, B Raij, JC Gonçalves Boletim Tecnico IAC, 247-59, 1996 | 78 | 1996 |
| Buildings: investing in energy and resource efficiency P Rode, R Burdett, JC Soares Gonçalves United Nations Environment Programme, 2011 | 72 | 2011 |
| Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples V Meireles, T Rosado, M Barroso, S Soares, J Gonçalves, Â Luís, ... Medicines 6 (1), 35, 2019 | 67 | 2019 |
| Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis. JM Sobell, P Foley, D Toth, U Mrowietz, G Girolomoni, J Goncalves, ... Acta dermato-venereologica 96 (4), 2016 | 64 | 2016 |
| Novel synthetic opioids–toxicological aspects and analysis I Tabarra, S Soares, T Rosado, J Gonçalves, Â Luís, S Malaca, M Barroso, ... Forensic Sciences Research 4 (2), 111-140, 2019 | 62 | 2019 |
| Efficacy and safety of apremilast in patients with moderate plaque psoriasis with lower BSA: week 16 results from the UNVEIL study. B Strober, J Bagel, M Lebwohl, JM Jackson, R Chen, J Goncalves, E Levi Journal of drugs in dermatology: JDD 16 (8), 801-808, 2017 | 59 | 2017 |
| Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid SL Silverman, A Kriegman, J Goncalves, F Kianifard, T Carlson, E Leary Osteoporosis international 22, 2337-2345, 2011 | 57 | 2011 |
| Safety and efficacy of non‐steroidal anti‐inflammatory drugs to reduce ileus after colorectal surgery EuroSurg Collaborative, SJ Chapman, D Clerc, R Blanco‐Colino, A Otto, ... British Journal of Surgery 107 (2), e161-e169, 2020 | 55 | 2020 |
| A vida nas águas das montanhas M Callisto, J Goncalves Ciência Hoje 31 (182), 68-71, 2002 | 54 | 2002 |
| Efficacy and Safety of Apremilast in Systemic-and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL. J Bagel, M Lebwohl, JM Jackson, R Chen, J Goncalves, E Levi, KC Duffin Journal of drugs in dermatology: JDD 17 (2), 221-228, 2018 | 53 | 2018 |
